Cargando…
Curcumol inhibits malignant biological behaviors and TMZ-resistance in glioma cells by inhibiting long noncoding RNA FOXD2-As1-promoted EZH2 activation
Currently, conventional treatment is not sufficient to improve the survival of glioma patients. Hence, adopting novel personalized treatment programs is imperative. Curcumol, a Chinese herbal medicine extract from the roots of Rhizoma Curcumae, has attracted significant interest due to its beneficia...
Autores principales: | Lv, Xuyang, Sun, Jiangchuan, Hu, Linfeng, Qian, Ying, Fan, Chunlei, Tian, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610140/ https://www.ncbi.nlm.nih.gov/pubmed/34739394 http://dx.doi.org/10.18632/aging.203662 |
Ejemplares similares
-
ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma
por: Han, Bo, et al.
Publicado: (2020) -
Hispidulin Enhances Temozolomide (TMZ)-Induced Cytotoxicity against Malignant Glioma Cells In Vitro by Inhibiting Autophagy
por: Chen, Zhihua, et al.
Publicado: (2022) -
TOPK inhibits autophagy by phosphorylating ULK1 and promotes glioma resistance to TMZ
por: Lu, Hui, et al.
Publicado: (2019) -
FoxD2-AS1 is a prognostic factor in glioma and promotes temozolomide resistance in a O(6)-methylguanine-DNA methyltransferase-dependent manner
por: Shangguan, Wenbing, et al.
Publicado: (2019) -
Curcumol Attenuates Endometriosis by Inhibiting the JAK2/STAT3 Signaling Pathway
por: Wang, Yan, et al.
Publicado: (2022)